The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway

Journal of Virology
Brenda L FredericksenMichael Gale

Abstract

Recent outbreaks of West Nile Virus (WNV) have been associated with an increase in morbidity and mortality in humans, birds, and many other species. We have initiated studies to define the molecular mechanisms by which a recent pathogenic isolate of WNV evades the host cell innate antiviral response. Biochemical and microarray analyses demonstrated that WNV induced the expression of beta interferon (IFN-beta) and several IFN-stimulated genes late in infection of cultured human cells. The late expression of these antiviral genes was due to the delayed activation of the transcription factor IFN regulatory factor 3 (IRF-3). Despite this host response, WNV was still able to replicate efficiently. The effect of the IRF-3 pathway on WNV replication was assessed by examining virus replication and spread in cultures of wild-type or IRF-3-null mouse embryo fibroblasts. The absence of IRF-3 was marked by a significant increase in plaque size and a sustained production of infectious particles. Although the activation of the IRF-3 pathway was not sufficient to block virus replication, our results suggest that IRF-3 target genes function to constrain WNV infection and limit cell-to-cell virus spread.

References

Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·S D DerR H Silverman
May 18, 2001·Biochemical and Biophysical Research Communications·T NakayaT Taniguchi
Sep 7, 2001·Annual Review of Microbiology·G C Sen
Oct 5, 2001·Emerging Infectious Diseases·L R Petersen, J T Roehrig
Jan 19, 2002·Annals of the New York Academy of Sciences·L D Kramer, K A Bernard
Feb 16, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Betsy BarnesPaula M Pitha
Feb 16, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Mitsutoshi YoneyamaTakashi Fujita
Mar 22, 2002·Journal of Virology·Benjamin R tenOeverJohn Hiscott
May 22, 2002·Journal of Virology·Pei-Yong ShiKristen A Bernard
Jul 27, 2002·Annual Review of Microbiology·Margo A Brinton
Aug 21, 2002·Journal of Virology·Joel W GraffMichele E Hardy
Sep 5, 2002·Nature Reviews. Immunology·Michael G KatzeMichael Gale
Sep 14, 2002·Advances in Biochemical Engineering/biotechnology·Alvis BrazmaKurt Fellenberg
Jan 2, 2003·The Journal of Biological Chemistry·Saumendra N SarkarGanes C Sen
Apr 15, 2003·Nature Immunology·Katherine A FitzgeraldTom Maniatis
Apr 30, 2003·Nature Immunology·Gregory M Barton, Ruslan Medzhitov
Nov 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jorge L Muñoz-JordanAdolfo García-Sastre
Dec 3, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maria W SmithMichael G Katze
Dec 31, 2003·Transplantation Proceedings·Z ArmaliZ S Azzam

❮ Previous
Next ❯

Citations

Dec 11, 2007·Nature Biotechnology·Seng-Lai TanMichael G Katze
Aug 22, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Michael S Diamond
Oct 5, 2012·Clinical Microbiology Reviews·Tonya M ColpittsErol Fikrig
Aug 24, 2007·Journal of Virology·Amine O NoueiryMichael S Diamond
Sep 6, 2005·Journal of Virology·Alec J HirschJay A Nelson
Jan 15, 2005·Journal of Virology·Ju-Tao GuoChristoph Seeger
Feb 28, 2006·Journal of Virology·Svetlana V ScherbikMargo A Brinton
Jan 1, 2009·Journal of Innate Immunity·Stephane DaffisMichael S Diamond
May 31, 2007·BMC Microbiology·Malte C KleinschmidtJindrich Cinatl
Sep 22, 2011·PloS One·Abigail W BighamMichael Bamshad
Jul 23, 2013·PloS One·Christophe FraisierLionel Almeras
Feb 9, 2010·PLoS Pathogens·Mehul S SutharMichael Gale
May 3, 2011·PLoS Pathogens·Miriam TriyatniBertrand Saunier
Apr 20, 2014·PLoS Pathogens·Amelia K PintoMichael S Diamond
Jul 3, 2010·The American Journal of Tropical Medicine and Hygiene·Stephanie L RichardsWalter J Tabachnick
Mar 25, 2014·Virus Research·Arshed NazmiAnirban Basu
Mar 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mario Barro, John T Patton
Jul 12, 2013·Journal of Neurovirology·Brenda L Fredericksen
Nov 26, 2005·Expert Review of Anti-infective Therapy·Michael S Diamond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.